Loss of U11 small nuclear RNA in the developing mouse limb results in micromelia

Kyle D Drake1, Christopher Lemoine1,2, Gabriela S Aquino1

  • 1Physiology and Neurobiology Department, University of Connecticut, Storrs, CT 06269, USA.

Development (Cambridge, England)
|July 16, 2020
PubMed

Insights

Disrupting the minor spliceosome, essential for cell cycle regulation, causes limb growth defects. This finding reveals a shared mechanism in primordial dwarfism and animal domestication.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Genetics

Background:

  • Mutations in RNU4ATAC disrupt the minor spliceosome, causing primordial dwarfism syndromes like Roifman syndrome.
  • Positive selection in minor spliceosome components is linked to dwarfism in domesticated animals.
  • The minor spliceosome's role in limb development and size regulation is largely unknown.

Purpose of the Study:

  • To investigate the function of the minor spliceosome in mammalian limb development.
  • To determine the molecular mechanisms underlying minor spliceosome-mediated size control.

Main Methods:

  • Ablation of U11 small nuclear RNA in developing mouse limbs to disrupt minor spliceosome function.
  • Analysis of limb size, cell cycle progression, and gene expression in affected limbs.

Main Results:

  • U11 ablation led to micromelia (reduced limb size).
  • Loss of U11 caused increased minor intron retention in cell cycle genes, leading to cell cycle delays (prometaphase-to-metaphase transition, S-phase).
  • Rapidly dividing progenitor cell death and limb size reduction occurred, yet limb patterning gene expression remained intact.

Conclusions:

  • The minor spliceosome is essential for normal limb development and size regulation in mice.
  • Minor intron retention and subsequent cell cycle defects in progenitor cells are key mechanisms for size control.
  • The findings suggest a conserved role for the minor spliceosome in size regulation relevant to both human diseases and animal domestication.